Compare GHI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Current Price
| Metric | GHI | OSUR |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.5M | 174.3M |
| IPO Year | N/A | 1986 |
| Metric | GHI | OSUR |
|---|---|---|
| Price | $6.84 | $2.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $13.00 | $3.00 |
| AVG Volume (30 Days) | 188.2K | ★ 674.1K |
| Earning Date | 02-19-2026 | 11-05-2025 |
| Dividend Yield | ★ 21.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | $26,247,399.00 | ★ $125,703,000.00 |
| Revenue This Year | $201.02 | N/A |
| Revenue Next Year | $2.87 | $3.70 |
| P/E Ratio | $40.13 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.01 | $2.08 |
| 52 Week High | $13.29 | $4.22 |
| Indicator | GHI | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 46.51 |
| Support Level | $6.99 | $2.41 |
| Resistance Level | $7.35 | $2.50 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 42.62 | 23.73 |
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.